227 related articles for article (PubMed ID: 1623765)
1. Ethical relationships between drug companies and the medical profession.
Rosner F
Chest; 1992 Jul; 102(1):266-9. PubMed ID: 1623765
[No Abstract] [Full Text] [Related]
2. Interactions between physicians and the pharmaceutical industry: what does the literature say?
Lexchin J
CMAJ; 1993 Nov; 149(10):1401-7. PubMed ID: 8221424
[TBL] [Abstract][Full Text] [Related]
3. The effects of pharmaceutical firm enticements on physician prescribing patterns. There's no such thing as a free lunch.
Orlowski JP; Wateska L
Chest; 1992 Jul; 102(1):270-3. PubMed ID: 1623766
[TBL] [Abstract][Full Text] [Related]
4. Pharmaceutical industry support for continuing medical education programs: a review of current ethical guidelines.
Rosner F
Mt Sinai J Med; 1995 Nov; 62(6):427-30. PubMed ID: 8692156
[TBL] [Abstract][Full Text] [Related]
5. [Conflict of interest in continuing medical education - Studies on certified CME courses].
Lenzen LM; Weidringer JW; Ollenschläger G
Z Evid Fortbild Qual Gesundhwes; 2016; 110-111():60-8. PubMed ID: 26875037
[TBL] [Abstract][Full Text] [Related]
6. AMA forges ahead. Unveiling of educational campaign paid by drug industry triggers new criticism.
Romano M
Mod Healthc; 2001 Sep; 31(37):22-3. PubMed ID: 11573355
[No Abstract] [Full Text] [Related]
7. [Editorial: Hebebrand, J., Blanz, B., Herpertz-Dahlmann, B. & Lehmkuhl, G. 2012. Increase in the abundance of medical treatments, ethical principles and conflicts of interest in cooperation with the pharmaceutical industry].
Frank R
Z Kinder Jugendpsychiatr Psychother; 2013 Mar; 41(2):145-9. PubMed ID: 23425616
[No Abstract] [Full Text] [Related]
8. Association between industry payments and prescriptions of long-acting insulin: An observational study with propensity score matching.
Inoue K; Tsugawa Y; Mangione CM; Duru OK
PLoS Med; 2021 Jun; 18(6):e1003645. PubMed ID: 34061852
[TBL] [Abstract][Full Text] [Related]
9. Reforming pharmaceutical industry-physician financial relationships: lessons from the United States, France, and Japan.
Rodwin MA
J Law Med Ethics; 2011; 39(4):662-70. PubMed ID: 22084852
[TBL] [Abstract][Full Text] [Related]
10. Pharmaceutical Industry Payments and Oncologists' Selection of Targeted Cancer Therapies in Medicare Beneficiaries.
Mitchell AP; Winn AN; Dusetzina SB
JAMA Intern Med; 2018 Jun; 178(6):854-856. PubMed ID: 29630687
[TBL] [Abstract][Full Text] [Related]
11. Future directions in industry funding of continuing medical education.
Steinbrook R
Arch Intern Med; 2011 Feb; 171(3):257-8. PubMed ID: 21325116
[No Abstract] [Full Text] [Related]
12. Doctors and the drug makers.
Rawlins MD
Lancet; 1984 Aug; 2(8397):276-8. PubMed ID: 6146822
[TBL] [Abstract][Full Text] [Related]
13. Considerations in the relationship between the American College of Chest Physicians and industry.
Lever A
Chest; 2001 Apr; 119(4):1257-9. PubMed ID: 11296196
[No Abstract] [Full Text] [Related]
14. AMA's gift guidelines.
Conley RB
Food Drug Cosmet Med Device Law Dig; 1993; 10():19-27. PubMed ID: 11654936
[No Abstract] [Full Text] [Related]
15. Industry support of physician education in the USA.
Fleischman W; Ross JS
J Epidemiol Community Health; 2017 Mar; 71(3):213-216. PubMed ID: 27612981
[No Abstract] [Full Text] [Related]
16. The drug industry and medical practice--the case of menopausal hormone therapy in Estonia.
Hemminki E; Karttunen T; Hovi SL; Karro H
Soc Sci Med; 2004 Jan; 58(1):89-97. PubMed ID: 14572923
[TBL] [Abstract][Full Text] [Related]
17. Psychiatrists' relationships with pharmaceutical companies: part of the problem or part of the solution?
Insel TR
JAMA; 2010 Mar; 303(12):1192-3. PubMed ID: 20332407
[No Abstract] [Full Text] [Related]
18. No more free lunches.
Abbasi K; Smith R
BMJ; 2003 May; 326(7400):1155-6. PubMed ID: 12775587
[No Abstract] [Full Text] [Related]
19. Physician-industry relations. Part 2: organizational issues.
Coyle SL;
Ann Intern Med; 2002 Mar; 136(5):403-6. PubMed ID: 11874315
[TBL] [Abstract][Full Text] [Related]
20. Medical commerce, physician entrepreneurialism, and conflicts of interest.
Rodwin MA
Camb Q Healthc Ethics; 2007; 16(4):387-97; discussion 439-42. PubMed ID: 18018918
[No Abstract] [Full Text] [Related]
[Next] [New Search]
